HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes.
Groop
Per-Henrik
PH
Folkhälsan Research Center, Biomedicum Helsinki, P.O. Box 63, FIN-00014 University of Helsinki, Finland. per-henrik.groop@helsinki.fi
Thomas
Merlin C
MC
Rosengård-Bärlund
Milla
M
Mills
Vashti
V
Rönnback
Mats
M
Thomas
Stephen
S
Forsblom
Carol
C
Taskinen
Maria-Rita
MR
Viberti
Giancarlo
G
D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000401:mortality; D015331:Cohort Studies; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications; D003925:Diabetic Angiopathies / Q000097:blood / Q000453:epidemiology* / Q000401:mortality; D003928:Diabetic Nephropathies / Q000453:epidemiology; D050171:Dyslipidemias / Q000097:blood / Q000150:complications; D005387:Finland / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008075:Lipoproteins, HDL / Q000097:blood*; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors; D006113:United Kingdom / Q000453:epidemiology
D008075:Lipoproteins, HDL